Teton Advisors’s Niagen Bioscience NAGE Stock Holding History

Teton Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.8K	Sell	25,000 -5,000	-17%	-$20.3K	0.05%	152
2026 Q1	$132K	Buy	30,000 +5,000	+20%	+$27K	0.09%	138
2025 Q4	$159K	Hold	25,000	–	–	0.11%	135
2025 Q3	$233K	Hold	25,000	–	–	0.14%	131
2025 Q2	$360K	Hold	25,000	–	–	0.22%	117
2025 Q1	$173K	Hold	25,000	–	–	0.11%	160
2024 Q4	$133K	Buy	25,000 +5,000	+25%	+$27.4K	0.07%	178
2024 Q3	$73K	Buy	+20,000	New	+$62.9K	0.03%	192

Other funds holding NAGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TCM

Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Teton Advisors's NAGE Position: Q2 2026 in Review

Teton Advisors reduced its Niagen Bioscience (NAGE) stake by 17% in Q2 2026, selling an estimated $20.3K and leaving 25,000 shares worth $79.8K. The position accounts for 0.05% of the portfolio, ranked #152.

Teton Advisors first reported a position in NAGE in Q3 2024 and has held it in 8 quarters since. The position peaked at $360K in Q2 2025. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

Teton Advisors held 25,000 shares of Niagen Bioscience worth $79.8K as of Q2 2026.
Teton Advisors sold 5,000 Niagen Bioscience shares in Q2 2026, an estimated $20.3K.
Niagen Bioscience made up 0.05% of Teton Advisors's portfolio in Q2 2026, its #152 holding.
Teton Advisors first reported a position in Niagen Bioscience in Q3 2024 and has held it in 8 quarters since.
Teton Advisors's Niagen Bioscience position peaked at $360K in Q2 2025.
140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Teton Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.